![JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania](https://www.mdpi.com/jcm/jcm-09-03826/article_deploy/html/images/jcm-09-03826-g001.png)
JCM | Free Full-Text | Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
![Tumor markers (PSA and CEA) levels of Prostate Cancer before and after... | Download Scientific Diagram Tumor markers (PSA and CEA) levels of Prostate Cancer before and after... | Download Scientific Diagram](https://www.researchgate.net/publication/290614365/figure/fig4/AS:670348085317653@1536834846755/Tumor-markers-PSA-and-CEA-levels-of-Prostate-Cancer-before-and-after-treatment-with.png)
Tumor markers (PSA and CEA) levels of Prostate Cancer before and after... | Download Scientific Diagram
![Tissue PSA distribution across the prostate gland at t = 0.5 y, tumor... | Download Scientific Diagram Tissue PSA distribution across the prostate gland at t = 0.5 y, tumor... | Download Scientific Diagram](https://www.researchgate.net/publication/310585827/figure/fig4/AS:431670072483843@1479929573889/Tissue-PSA-distribution-across-the-prostate-gland-at-t-05-y-tumor-volume-evolution.png)
Tissue PSA distribution across the prostate gland at t = 0.5 y, tumor... | Download Scientific Diagram
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image11.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Ontario Ministry of Health and Long-Term Care - Healthcare Providers - Publications - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines - Summary Ontario Ministry of Health and Long-Term Care - Healthcare Providers - Publications - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines - Summary](https://www.health.gov.on.ca/english/providers/pub/cancer/psa/psa_summary/screening.gif)
Ontario Ministry of Health and Long-Term Care - Healthcare Providers - Publications - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines - Summary
![JCM | Free Full-Text | The Importance of Time to Prostate-Specific Antigen ( PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients JCM | Free Full-Text | The Importance of Time to Prostate-Specific Antigen ( PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients](https://pub.mdpi-res.com/jcm/jcm-07-00565/article_deploy/html/images/jcm-07-00565-g001.png?1570842703)
JCM | Free Full-Text | The Importance of Time to Prostate-Specific Antigen ( PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients
![Cancers | Free Full-Text | Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide Cancers | Free Full-Text | Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide](https://pub.mdpi-res.com/cancers/cancers-14-02219/article_deploy/html/images/cancers-14-02219-ag-550.jpg?1665133134)
Cancers | Free Full-Text | Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/fbc9fb93-c826-43a7-b92a-ac0d1359335c/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology](https://www.auajournals.org/cms/asset/3e9b0bb9-dff8-4dc9-a376-6265bd3e4176/abs-fig.jpg)